0001209191-21-041091.txt : 20210616
0001209191-21-041091.hdr.sgml : 20210616
20210616190129
ACCESSION NUMBER: 0001209191-21-041091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210614
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butt Tausif
CENTRAL INDEX KEY: 0001845266
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 211022814
MAIL ADDRESS:
STREET 1: C/O CHEMOCENTRYX, INC.
STREET 2: 850 MAUDE AVE.
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD
STREET 2: SUITE 600
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD
STREET 2: SUITE 600
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-14
0
0001340652
ChemoCentryx, Inc.
CCXI
0001845266
Butt Tausif
C/O CHEMOCENTRYX, INC.
835 INDUSTRIAL ROAD, SUITE 600
SAN CARLOS
CA
94070
0
1
0
0
EVP, Chief Operating Officer
Stock Option (right to buy)
13.17
2021-06-14
4
A
0
75000
A
2031-06-14
Common Stock
75000
75000
D
The option was granted on June 14, 2021, and 25% of the total number of shares of common stock subject to the option vests on June 14, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
Not applicable.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2021-06-16